Publications by authors named "Tina Atkinson"

Claim this Profile
A
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Susana M Campos, Suzanne Berlin, Carolyn N Krasner, Christin Whalen, Tina Atkinson

Cancer Chemother Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Marcela G Del Carmen, Jeff G Supko, Nora K Horick, J Alejandro Rauh-Hain, Rachel M Clark, Tina Atkinson

Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study.
Joo Ern Ang, Charlie Gourley, C Bethan Powell, Hilda High, Ronnie Shapira-Frommer, Tina Atkinson

Clin Cancer Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer.
Ursula A Matulonis, Lauren Pereira, Joyce Liu, Hang Lee, Julie Lee, Tina Atkinson

Gynecol Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.
Susana M Campos, Suzanne T Berlin, Leroy M Parker, Wendy Y Chen, Craig A Bunnell, Tina Atkinson

Int J Clin Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
Ursula A Matulonis, Karen J Krag, Carolyn N Krasner, Tina Atkinson, Neil S Horowitz

Gynecol Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
Ursula A Matulonis, Michael V Seiden, Maria Roche, Carolyn Krasner, Arlan F Fuller, Tina Atkinson

J Pain Symptom Manage· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
Linda R Duska, Ross Berkowitz, Ursula Matulonis, Michael Muto, Annekathryn Goodman, Tina Atkinson

Gynecol Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
Anna Berkenblit, Michael V Seiden, Ursula A Matulonis, Richard T Penson, Carolyn N Krasner, Tina Atkinson

Gynecol Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.
Richard T Penson, Michael V Seiden, Annekathryn Goodman, Arlan F Fuller, Ross S Berkowitz, Tina Atkinson

Gynecol Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis